HER2+ Inflammatory Breast Cancer: Neoadjuvant Approaches
1 مناظر
• 07/03/23
0
0
ایمبیڈ
administrator
سبسکرائبرز
Debu Tripathy, MD, shares insight on the optimal neoadjuvant approaches to HER2+ inflammatory breast cancer with regard to the availability of hormonal and chemotherapeutic agents.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
مزید دکھائیں
فیس بک کے تبصرے
SORT BY-
سرفہرست تبصرے
-
تازہ ترین تبصرے